Claraphi Advisory Network’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-9,408
Closed -$861K 310
2021
Q2
$861K Sell
9,408
-5,997
-39% -$477K 0.26% 82
2021
Q1
$1.05M Buy
15,405
+836
+6% +$64.9K 0.29% 73
2020
Q4
$1.06M Buy
14,569
+6,317
+77% +$366K 0.29% 62
2020
Q3
$313K Buy
+8,252
New +$279K 0.11% 173

Other funds holding CDNA

Claraphi Advisory Network's CDNA Position: Q3 2021 in Review

Claraphi Advisory Network sold out of CareDx (CDNA) in Q3 2021, closing a stake of 9,408 shares — an estimated $861K sold.

Claraphi Advisory Network first reported a position in CDNA in Q3 2020 and held it in 4 quarters. The position peaked at $1.06M in Q4 2020. 260 funds tracked by Wall St. Rank hold CDNA as of Q3 2021.

  • Claraphi Advisory Network reported no remaining CareDx position as of Q3 2021 after selling out during the quarter.
  • Claraphi Advisory Network sold 9,408 CareDx shares in Q3 2021, an estimated $861K.
  • Claraphi Advisory Network first reported a position in CareDx in Q3 2020 and held it in 4 quarters.
  • Claraphi Advisory Network's CareDx position peaked at $1.06M in Q4 2020.
  • 260 funds tracked by Wall St. Rank held CareDx as of Q3 2021.

Based on Claraphi Advisory Network's 13F filing for Q3 2021, filed 15 Nov 2021.